Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 2 for:    vedolizumab adalimumab | ulcerative colitis | Italy

Entyvio (Vedolizumab) Long Term Safety Study (Entyvio PASS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02674308
Recruitment Status : Active, not recruiting
First Posted : February 4, 2016
Last Update Posted : April 14, 2021
Sponsor:
Information provided by (Responsible Party):
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 30, 2021
Estimated Study Completion Date : July 30, 2021